Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in XBIO — Xenetic Biosciences, Inc.

CIK 1214717 BOSTON, MA
Back to XBIO Full portfolio

Position in XBIO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$50,700
-$6,761 QoQ
Shares Held
17,423
-18.7% QoQ
Ownership
0.744%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 8 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,296,497 across 521 Biotechnology names. XBIO ranks #476 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in XBIO

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $50,700 17,423
2026-03-31 $57,461 21,441
2025-12-31 $29,470 13,581
2025-09-30 $33,547 10,684
2025-06-30 $41,073 10,478
2025-03-31 $28,587 10,953
2024-12-31 $47,436 11,889
2024-09-30 $51,360 11,889
2024-06-30 $48,790 11,988
2024-03-31 $41,462 10,998
2023-12-31 $37,943 10,998
2023-09-30 $53,890 10,998
2023-03-31 $37,167 91,545
2022-12-31 $26,317 92,343
2022-09-30 $49,726 92,601
2022-06-30 $74,173 92,601
2022-03-31 $92,764 90,946
2021-12-31 $117,320 90,946
2021-09-30 $213,513 104,153
2021-06-30 $103,040 50,510
2021-03-31 $68,148 31,261
2020-12-31 $26,895 13,184